1. Moroishi, Toshiro, Hayashi, Tomoko, Pan, Wei-Wei, Carson, Dennis A, Guan, Kun-Liang. . The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity. In Cell, 167, 1525-1539.e17. doi:10.1016/j.cell.2016.11.005. https://pubmed.ncbi.nlm.nih.gov/27912060/
2. Qi, Sixian, Zhu, Yuwen, Liu, Xincheng, Zhang, Lei, Yu, Fa-Xing. 2022. WWC proteins mediate LATS1/2 activation by Hippo kinases and imply a tumor suppression strategy. In Molecular cell, 82, 1850-1864.e7. doi:10.1016/j.molcel.2022.03.027. https://pubmed.ncbi.nlm.nih.gov/35429439/
3. Goel, Harsh, Mathur, Runjhun, Syeda, Saima, Shrivastava, Anju, Jha, Abhimanyu Kumar. 2021. Promoter Hypermethylation of LATS1 Gene in Oral Squamous Cell Carcinoma (OSCC) among North Indian Population. In Asian Pacific journal of cancer prevention : APJCP, 22, 977-982. doi:10.31557/APJCP.2021.22.3.977. https://pubmed.ncbi.nlm.nih.gov/33773564/
4. Li, Rui-Hua, Tian, Tian, Ge, Qi-Wei, Zhou, Tianhua, Lin, Aifu. 2021. A phosphatidic acid-binding lncRNA SNHG9 facilitates LATS1 liquid-liquid phase separation to promote oncogenic YAP signaling. In Cell research, 31, 1088-1105. doi:10.1038/s41422-021-00530-9. https://pubmed.ncbi.nlm.nih.gov/34267352/
5. Yang, Qianlan, Lv, Zehen, Wang, Mengfei, Gao, Kun, Wan, Xiaoping. 2024. LATS1/2 loss promote tumor immune evasion in endometrial cancer through downregulating MHC-I expression. In Journal of experimental & clinical cancer research : CR, 43, 54. doi:10.1186/s13046-024-02979-z. https://pubmed.ncbi.nlm.nih.gov/38383447/
6. Zheng, Mingjie, Li, Rich G, Song, Jia, Li, Na, Wang, Jun. 2022. Hippo-Yap Signaling Maintains Sinoatrial Node Homeostasis. In Circulation, 146, 1694-1711. doi:10.1161/CIRCULATIONAHA.121.058777. https://pubmed.ncbi.nlm.nih.gov/36317529/
7. Yu, Fa-Xing, Zhao, Bin, Panupinthu, Nattapon, Mills, Gordon B, Guan, Kun-Liang. 2012. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. In Cell, 150, 780-91. doi:10.1016/j.cell.2012.06.037. https://pubmed.ncbi.nlm.nih.gov/22863277/
智鼠故事 
